The BabySeq Project

There is growing societal and scientific interest in using genomic sequencing as screening to identify genetic predispositions for disease early in life to prevent or mitigate future illness. There is, however, skepticism about the clinical utility of its use in infants and concerns that it could lead to psychosocial harm, unjustified health expenditures, and unnecessary healthcare utilization.

The BabySeq Project is a randomized trial to study medical, behavioral and economic outcomes associated with implementing genomic sequencing in an under-represented population of infants at clinical sites across the U.S. serving ethnically, racially and socio-economically diverse populations.